Miransertib (MK-7075)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Miransertib (MK-7075), covering 2026-04-17 to 2026-04-17. Get the full timeline:
Most recent: Clinical Trial Update: MK-7075 (Miransertib) in Proteus Syndrome [Phase 2]